GYROX
Bugworks Research bags $18 million in funding round led by Lightrock India, othersBugworks Research said it will continue to invest in its proprietary drug discovery platforms GYROX (for AMR) and DARE (for Immuno-oncology...
Biopharma startup Bugworks raises $7.5 million in fresh financing roundThe latest capital raise will allow the company to complete its phase-1 studies for its GYROX series intravenous drug candidate, as well as...
Government seeks to set ground rules for GyroplanesSeven conditions have been spelt out by the government in its draft policy on gyroplanes after years of consultations between the ministrie...
- Load More